Page last updated: 2024-08-21

isoxazoles and vorinostat

isoxazoles has been researched along with vorinostat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Budillon, A; Caraglia, M; Carbone, C; Di Gennaro, E; Milone, MR; Piro, G; Pucci, B	1

Other Studies

1 other study(ies) available for isoxazoles and vorinostat

Article	Year
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat. Amino acids, 2017, Volume: 49, Issue:3 Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; GTP-Binding Proteins; HCT116 Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; HT29 Cells; Humans; Hydroxamic Acids; Isoxazoles; MCF-7 Cells; Protein Glutamine gamma Glutamyltransferase 2; RNA, Small Interfering; Signal Transduction; Transglutaminases; Vorinostat	2017

Article

Year

Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.

Amino acids, 2017, Volume: 49, Issue:3

Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; GTP-Binding Proteins; HCT116 Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; HT29 Cells; Humans; Hydroxamic Acids; Isoxazoles; MCF-7 Cells; Protein Glutamine gamma Glutamyltransferase 2; RNA, Small Interfering; Signal Transduction; Transglutaminases; Vorinostat

2017